On October 29, 2018, DISA Global Solutions hosted its very first ‘Day with DISA’ conference. This drug testing symposium helped educate employers on trending topics in the industry that directly impact workplace safety and compliance. Employers who comply with the Department of Transportation (DOT) for their business have specific guidelines and policies that they must follow, which often contradict or cause confusion with the everchanging marijuana legalization laws which vary by state. The symposium helped to address and clarify topics that the DOT specifies, while also clarifying the differences laws with non-DOT employees versus DOT employees.
This is a deep dive into the complexities of the DOT’s drug testing regulations and was presented in October 2018. If you want to focus on the latest 2019 Drug & Alcohol Testing rates click here.
If you didn’t get the opportunity to attend the Day with DISA conference, or if you would like to review this presentation again, you can download or watch it using the link below.
DISA invited Dr. Donna Smith, Senior Consultant at Current Consulting, to present on drug testing for safety-sensitive positions, specifically those in the Department of Transportation (DOT). The ever changing and evolving laws on the legalization of marijuana make it increasingly difficult for employers to stay-up-to-date, and those in the DOT industry are faced with strict guidelines that must be adhered to, to maintain compliance and meet safety standards.
Dr. Smith addressed updates on DOT regulations, use vs. abuse, age of prescriptions, Medical Disclosure Policies, and safety concerns from the Medical Review Officer (MRO). Here are some key takeaways to keep in mind:
71% affected by employee use of prescription drugs
47% absenteeism or impaired worker performance
26% near-miss/injury, overdose, or arrest
Forming a clear and concise policy is a priority for employers, especially those who do business with DOT regulations as they do not always coincide with the state laws. “You cannot have a one-size-fits-all policy”, states Dr. Smith. “You have to be able to assess and evaluate the potential risks associated with not having good, medical information about your employees. Certainly, for employees that you require a medical exam for on a recurring basis.”
With the opioid epidemic on the rise and marijuana laws changing by state and by day, employers have got to be as precise as possible when forming a medical disclosure policy to protect their employees and companies. Dr. Smith indicates that “for the first time, from 2012 to 2016, the National Survey on Drug Use and Health has had misuse or abuse of prescription drug use as the second highest category in drug use, with marijuana being first.” With prescription abuse on the rise, along with the legalization in marijuana laws, employers must be more aware of the DOT regulations and enforce them, regardless of state laws.
Read about other presentations from Day with DISA:
For more than 30 years, DISA has been a provider of workplace safety and compliance services. DISA helps companies make more informed staffing decisions by offering a broad array of industry-leading methodologies to make employee screening faster and more accurate. For more information about DISA call 1-800-752-6432 or email firstname.lastname@example.org.